{"entity":{"type":"insider","cik":"0001613084","url":"/insider/0001613084","json_url":"/insider/0001613084.json","name":"Doshi Dipal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":28,"first":"2015-07-09","last":"2024-07-16","span_basis":"filed_date"},"name_variants":[{"name":"Doshi Dipal","source":"filing","n_filings":28,"first_seen":"2015-07-09","last_seen":"2024-07-16"}],"transactions":[{"id":2260772,"accession":"0001689375-24-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000040","line_url":"/filing/0001689375-24-000040#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":17.8108,"price_display":"17.81","price_state":"stated","total_value":28497.28,"total_display":"28,497.28","shares_owned_after":334475.0,"shares_owned_after_display":"334,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-16","scope":"insider"},{"id":2260771,"accession":"0001689375-24-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000040","line_url":"/filing/0001689375-24-000040#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","shares_owned_after":336075.0,"shares_owned_after_display":"336,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-12","filed_date":"2024-07-16","scope":"insider"},{"id":2226921,"accession":"0001689375-24-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000033","line_url":"/filing/0001689375-24-000033#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.1736,"price_display":"16.17","price_state":"stated","total_value":16173.6,"total_display":"16,173.60","shares_owned_after":336375.0,"shares_owned_after_display":"336,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-14","scope":"insider"},{"id":2049990,"accession":"0001689375-24-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000030","line_url":"/filing/0001689375-24-000030#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":15.1076,"price_display":"15.11","price_state":"stated","total_value":18129.12,"total_display":"18,129.12","shares_owned_after":337375.0,"shares_owned_after_display":"337,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-20","scope":"insider"},{"id":2049989,"accession":"0001689375-24-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000030","line_url":"/filing/0001689375-24-000030#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":27000.0,"total_display":"27,000.00","shares_owned_after":338575.0,"shares_owned_after_display":"338,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2872766,"accession":"0001689375-24-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000002","line_url":"/filing/0001689375-24-000002#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":243279.0,"shares_owned_after_display":"243,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":2098323,"accession":"0001689375-24-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000001","line_url":"/filing/0001689375-24-000001#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.99,"price_display":"15.99","price_state":"stated","total_value":15990.0,"total_display":"15,990.00","shares_owned_after":244279.0,"shares_owned_after_display":"244,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8378637,"accession":"0001689375-23-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000076","line_url":"/filing/0001689375-23-000076#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":245279.0,"shares_owned_after_display":"245,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-22","scope":"insider"},{"id":8212160,"accession":"0001689375-23-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000075","line_url":"/filing/0001689375-23-000075#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.23,"price_display":"16.23","price_state":"stated","total_value":16230.0,"total_display":"16,230.00","shares_owned_after":246279.0,"shares_owned_after_display":"246,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-13","scope":"insider"},{"id":8716844,"accession":"0001689375-23-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000069","line_url":"/filing/0001689375-23-000069#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":247279.0,"shares_owned_after_display":"247,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-17","filed_date":"2023-10-19","scope":"insider"},{"id":8640564,"accession":"0001689375-23-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000066","line_url":"/filing/0001689375-23-000066#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":248279.0,"shares_owned_after_display":"248,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-15","scope":"insider"},{"id":8212159,"accession":"0001689375-23-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000056","line_url":"/filing/0001689375-23-000056#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.6713,"price_display":"15.67","price_state":"stated","total_value":15671.3,"total_display":"15,671.30","shares_owned_after":201069.0,"shares_owned_after_display":"201,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-16","scope":"insider"},{"id":8757052,"accession":"0001689375-23-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000033","line_url":"/filing/0001689375-23-000033#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.7109,"price_display":"13.71","price_state":"stated","total_value":27421.8,"total_display":"27,421.80","shares_owned_after":202069.0,"shares_owned_after_display":"202,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-05-01","scope":"insider"},{"id":8716840,"accession":"0001689375-23-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000032","line_url":"/filing/0001689375-23-000032#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2092.0,"shares_display":"2,092","price_per_share":18.0092,"price_display":"18.01","price_state":"stated","total_value":37675.2464,"total_display":"37,675.25","shares_owned_after":204069.0,"shares_owned_after_display":"204,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-19","scope":"insider"},{"id":7822892,"accession":"0001689375-23-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-23-000020","line_url":"/filing/0001689375-23-000020#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":14.6296,"price_display":"14.63","price_state":"stated","total_value":26333.28,"total_display":"26,333.28","shares_owned_after":256011.0,"shares_owned_after_display":"256,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-29","scope":"insider"},{"id":7822889,"accession":"0001689375-23-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000020","line_url":"/filing/0001689375-23-000020#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":15.51,"price_display":"15.51","price_state":"stated","total_value":3102.0,"total_display":"3,102.00","shares_owned_after":255811.0,"shares_owned_after_display":"255,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-29","scope":"insider"},{"id":8662384,"accession":"0001689375-23-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000009","line_url":"/filing/0001689375-23-000009#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":24000.0,"total_display":"24,000.00","shares_owned_after":161835.0,"shares_owned_after_display":"161,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-02","scope":"insider"},{"id":8564943,"accession":"0001689375-23-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000005","line_url":"/filing/0001689375-23-000005#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.0005,"price_display":"12.00","price_state":"stated","total_value":24001.0,"total_display":"24,001.00","shares_owned_after":163835.0,"shares_owned_after_display":"163,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-30","scope":"insider"},{"id":8239478,"accession":"0001689375-23-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000004","line_url":"/filing/0001689375-23-000004#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2410.0,"shares_display":"2,410","price_per_share":15.0189,"price_display":"15.02","price_state":"stated","total_value":36195.549,"total_display":"36,195.55","shares_owned_after":165835.0,"shares_owned_after_display":"165,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-10","scope":"insider"},{"id":6960876,"accession":"0001689375-22-000050","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000050","line_url":"/filing/0001689375-22-000050#line-4","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":15.0128,"price_display":"15.01","price_state":"stated","total_value":6005.12,"total_display":"6,005.12","shares_owned_after":168245.0,"shares_owned_after_display":"168,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2022-12-29","scope":"insider"},{"id":6960874,"accession":"0001689375-22-000050","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-22-000050","line_url":"/filing/0001689375-22-000050#line-3","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4521.0,"shares_display":"4,521","price_per_share":15.0081,"price_display":"15.01","price_state":"stated","total_value":67851.6201,"total_display":"67,851.62","shares_owned_after":168645.0,"shares_owned_after_display":"168,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-29","scope":"insider"},{"id":6960871,"accession":"0001689375-22-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000050","line_url":"/filing/0001689375-22-000050#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9069.0,"shares_display":"9,069","price_per_share":15.0384,"price_display":"15.04","price_state":"stated","total_value":136383.2496,"total_display":"136,383.25","shares_owned_after":173166.0,"shares_owned_after_display":"173,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-29","scope":"insider"},{"id":6960869,"accession":"0001689375-22-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000050","line_url":"/filing/0001689375-22-000050#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.7989,"price_display":"14.80","price_state":"stated","total_value":8879.34,"total_display":"8,879.34","shares_owned_after":182235.0,"shares_owned_after_display":"182,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-29","scope":"insider"},{"id":6335209,"accession":"0001689375-22-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000047","line_url":"/filing/0001689375-22-000047#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.9131,"price_display":"13.91","price_state":"stated","total_value":27826.2,"total_display":"27,826.20","shares_owned_after":182835.0,"shares_owned_after_display":"182,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-30","scope":"insider"},{"id":6584209,"accession":"0001689375-22-000037","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000037","line_url":"/filing/0001689375-22-000037#line-4","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":21.6625,"price_display":"21.66","price_state":"stated","total_value":43325.0,"total_display":"43,325.00","shares_owned_after":184835.0,"shares_owned_after_display":"184,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-10-27","scope":"insider"},{"id":6584207,"accession":"0001689375-22-000037","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-22-000037","line_url":"/filing/0001689375-22-000037#line-3","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7506.0,"shares_display":"7,506","price_per_share":20.7578,"price_display":"20.76","price_state":"stated","total_value":155808.0468,"total_display":"155,808.05","shares_owned_after":188335.0,"shares_owned_after_display":"188,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":6584205,"accession":"0001689375-22-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000037","line_url":"/filing/0001689375-22-000037#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3055.0,"shares_display":"3,055","price_per_share":20.009,"price_display":"20.01","price_state":"stated","total_value":61127.495,"total_display":"61,127.50","shares_owned_after":195841.0,"shares_owned_after_display":"195,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":6584203,"accession":"0001689375-22-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000037","line_url":"/filing/0001689375-22-000037#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":21.5007,"price_display":"21.50","price_state":"stated","total_value":32251.05,"total_display":"32,251.05","shares_owned_after":186835.0,"shares_owned_after_display":"186,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":6464725,"accession":"0001689375-22-000035","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000035","line_url":"/filing/0001689375-22-000035#line-4","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":19.6456,"price_display":"19.65","price_state":"stated","total_value":24380.1896,"total_display":"24,380.19","shares_owned_after":198896.0,"shares_owned_after_display":"198,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-24","scope":"insider"},{"id":6464722,"accession":"0001689375-22-000035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-22-000035","line_url":"/filing/0001689375-22-000035#line-3","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1101.0,"shares_display":"1,101","price_per_share":18.8999,"price_display":"18.90","price_state":"stated","total_value":20808.7899,"total_display":"20,808.79","shares_owned_after":200137.0,"shares_owned_after_display":"200,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-24","scope":"insider"},{"id":6464720,"accession":"0001689375-22-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000035","line_url":"/filing/0001689375-22-000035#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2786.0,"shares_display":"2,786","price_per_share":18.2759,"price_display":"18.28","price_state":"stated","total_value":50916.6574,"total_display":"50,916.66","shares_owned_after":201238.0,"shares_owned_after_display":"201,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-10-24","scope":"insider"},{"id":6464717,"accession":"0001689375-22-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000035","line_url":"/filing/0001689375-22-000035#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":811.0,"shares_display":"811","price_per_share":18.0113,"price_display":"18.01","price_state":"stated","total_value":14607.1643,"total_display":"14,607.16","shares_owned_after":204024.0,"shares_owned_after_display":"204,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-20","filed_date":"2022-10-24","scope":"insider"},{"id":6104581,"accession":"0001689375-22-000034","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001689375-22-000034","line_url":"/filing/0001689375-22-000034#line-5","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3085.0,"shares_display":"3,085","price_per_share":15.2339,"price_display":"15.23","price_state":"stated","total_value":46996.5815,"total_display":"46,996.58","shares_owned_after":204835.0,"shares_owned_after_display":"204,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-28","scope":"insider"},{"id":6104580,"accession":"0001689375-22-000034","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000034","line_url":"/filing/0001689375-22-000034#line-4","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3453.0,"shares_display":"3,453","price_per_share":15.0402,"price_display":"15.04","price_state":"stated","total_value":51933.8106,"total_display":"51,933.81","shares_owned_after":208886.0,"shares_owned_after_display":"208,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-28","scope":"insider"},{"id":6104577,"accession":"0001689375-22-000034","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-22-000034","line_url":"/filing/0001689375-22-000034#line-3","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":966.0,"shares_display":"966","price_per_share":15.824,"price_display":"15.82","price_state":"stated","total_value":15285.984,"total_display":"15,285.98","shares_owned_after":207920.0,"shares_owned_after_display":"207,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-28","scope":"insider"},{"id":6104575,"accession":"0001689375-22-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000034","line_url":"/filing/0001689375-22-000034#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2795.0,"shares_display":"2,795","price_per_share":15.2165,"price_display":"15.22","price_state":"stated","total_value":42530.1175,"total_display":"42,530.12","shares_owned_after":212627.0,"shares_owned_after_display":"212,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-28","scope":"insider"},{"id":6104572,"accession":"0001689375-22-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000034","line_url":"/filing/0001689375-22-000034#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":288.0,"shares_display":"288","price_per_share":16.3028,"price_display":"16.30","price_state":"stated","total_value":4695.2064,"total_display":"4,695.21","shares_owned_after":212339.0,"shares_owned_after_display":"212,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-28","scope":"insider"},{"id":6163237,"accession":"0001689375-22-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000031","line_url":"/filing/0001689375-22-000031#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1023.0,"shares_display":"1,023","price_per_share":15.066,"price_display":"15.07","price_state":"stated","total_value":15412.518,"total_display":"15,412.52","shares_owned_after":215422.0,"shares_owned_after_display":"215,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-23","scope":"insider"},{"id":6163234,"accession":"0001689375-22-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000031","line_url":"/filing/0001689375-22-000031#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3402.0,"shares_display":"3,402","price_per_share":15.1162,"price_display":"15.12","price_state":"stated","total_value":51425.3124,"total_display":"51,425.31","shares_owned_after":216445.0,"shares_owned_after_display":"216,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-23","scope":"insider"},{"id":6464714,"accession":"0001689375-22-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000028","line_url":"/filing/0001689375-22-000028#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":15.04,"price_display":"15.04","price_state":"stated","total_value":3008.0,"total_display":"3,008.00","shares_owned_after":219847.0,"shares_owned_after_display":"219,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider"},{"id":6611385,"accession":"0001689375-22-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000022","line_url":"/filing/0001689375-22-000022#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":688.0,"shares_display":"688","price_per_share":15.0669,"price_display":"15.07","price_state":"stated","total_value":10366.0272,"total_display":"10,366.03","shares_owned_after":220047.0,"shares_owned_after_display":"220,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-09","filed_date":"2022-09-12","scope":"insider"},{"id":6611380,"accession":"0001689375-22-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000022","line_url":"/filing/0001689375-22-000022#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":15.1577,"price_display":"15.16","price_state":"stated","total_value":16673.47,"total_display":"16,673.47","shares_owned_after":220735.0,"shares_owned_after_display":"220,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-12","scope":"insider"},{"id":6439490,"accession":"0001689375-22-000016","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001689375-22-000016","line_url":"/filing/0001689375-22-000016#line-5","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":171.0,"shares_display":"171","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2052.0,"total_display":"2,052.00","shares_owned_after":206710.0,"shares_owned_after_display":"206,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-31","filed_date":"2022-08-31","scope":"insider"},{"id":6439488,"accession":"0001689375-22-000016","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000016","line_url":"/filing/0001689375-22-000016#line-4","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190.0,"shares_display":"190","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2280.0,"total_display":"2,280.00","shares_owned_after":206881.0,"shares_owned_after_display":"206,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-30","filed_date":"2022-08-31","scope":"insider"},{"id":6439485,"accession":"0001689375-22-000016","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-22-000016","line_url":"/filing/0001689375-22-000016#line-3","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1109.0,"shares_display":"1,109","price_per_share":12.5615,"price_display":"12.56","price_state":"stated","total_value":13930.7035,"total_display":"13,930.70","shares_owned_after":207601.0,"shares_owned_after_display":"207,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-29","filed_date":"2022-08-31","scope":"insider"},{"id":6439483,"accession":"0001689375-22-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000016","line_url":"/filing/0001689375-22-000016#line-2","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":505.0,"shares_display":"505","price_per_share":13.5097,"price_display":"13.51","price_state":"stated","total_value":6822.3985,"total_display":"6,822.40","shares_owned_after":207096.0,"shares_owned_after_display":"207,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-29","filed_date":"2022-08-31","scope":"insider"},{"id":6439480,"accession":"0001689375-22-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000016","line_url":"/filing/0001689375-22-000016#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25.0,"shares_display":"25","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":350.0,"total_display":"350.00","shares_owned_after":207071.0,"shares_owned_after_display":"207,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-29","filed_date":"2022-08-31","scope":"insider"},{"id":6403428,"accession":"0001104659-22-084212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-084212","line_url":"/filing/0001104659-22-084212#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":24000.0,"total_display":"24,000.00","shares_owned_after":208710.0,"shares_owned_after_display":"208,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-29","scope":"insider"},{"id":6927785,"accession":"0001104659-22-075786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-075786","line_url":"/filing/0001104659-22-075786#line-1","is_derivative":false,"issuer_cik":"0001613084","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001613084","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","shares_owned_after":210710.0,"shares_owned_after_display":"210,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":8094079,"accession":"0001209191-15-060323","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-060323","line_url":"/filing/0001209191-15-060323#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001613084","owner_name":"Doshi Dipal","owner_url":"/insider/0001613084","role":"Officer (SVP Strategy & Bus Dev)","officer_title":"SVP Strategy & Bus Dev","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":13.8703,"price_display":"13.87","price_state":"stated","total_value":86689.375,"total_display":"86,689.38","shares_owned_after":1706.0,"shares_owned_after_display":"1,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-08","filed_date":"2015-07-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":50,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":50,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":50},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689375","name":"Entrada Therapeutics, Inc.","url":"/issuer/0001689375","role":"Director, Officer (CEO)","n_filings":27,"first_seen":"2022-06-29","last_seen":"2024-07-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Officer (SVP Strategy & Bus Dev)","n_filings":1,"first_seen":"2015-07-09","last_seen":"2015-07-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001613084","retrieved_at":"2026-08-21T09:26:14+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}